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Abstract
Objectives: A number of neurodegenerative diseases progress with a loss of myelin, which makes them candidate diseases
for the development of cell-replacement therapies based on mobilisation or isolation of the endogenous neural/glial
progenitor cells, in vitro expansion, and further implantation. Cells expressing A2B5 or PDGFRA/CNP have been isolated
within the pool of glial progenitor cells in the subcortical white matter of the normal adult human brain, all of which
demonstrate glial progenitor features. However, the heterogeneity and differentiation potential of this pool of cells is not
yet well established.
Methods: We used diffusion tensor images, histopathology, and immunostaining analysis to demonstrate normal
cytoarchitecture and the absence of abnormalities in human temporal lobe samples from patients with mesial temporal
sclerosis. These samples were used to isolate and enrich glial progenitor cells in vitro, and later to detect such cells in vivo.
Results: We have identified a subpopulation of SOX2+ cells, most of them co-localising with OLIG2, in the white matter of
the normal adult human brain in vivo. These cells can be isolated and enriched in vitro, where they proliferate and generate
immature (O4+) and mature (MBP+) oligodendrocytes and, to a lesser extent, astrocytes (GFAP+).
Conclusion: Our results demonstrate the existence of a new glial progenitor cell subpopulation that expresses SOX2 in the
white matter of the normal adult human brain. These cells might be of use for tissue regeneration procedures.
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Introduction
A significant number of neurodegenerative diseases that affect
the central nervous system progress with a loss of myelin. Within
this group of diseases, multiple sclerosis (MS) is the most common
cause of neurological disability in young adults [1,2] and is a
candidate disease for the development of cell therapies. The
mobilisation of endogenous neural/glial progenitor cells, the
isolation of these cells, and their in vitro expansion and implanta-
tion in the same patient within the most invalidating of the chronic
sclerotic MS plaques in the brain might be the most promising of
approaches. This idea has been reinforced by a number of reports
describing a pool of oligodendrocyte progenitor cells (OPCs) [3–5]
within the parenchyma of the adult human brain, which might be
responsible for the spontaneous myelination observed in patients
with MS [6]. Therefore, the identification and isolation of the
various subpopulations within the OPC pool and the evaluation of
their potential for generating oligodendrocytes in vitro will be
essential for modulating their migration, differentiation, and
integration in vivo in the damaged brain area. Additionally,
primary cell cultures represent an invaluable model for testing
the responsiveness of OPCs to drugs and growth factors, as well as
for accurately defining the differentiation processes that result in
fully functional oligodendrocytes.
Various subpopulations of OPCs have been purified from adult
human brain samples according to the expression of A2B5,
CNPase, or PDGFRA [3–5,7–9] and expanded in vitro. However,
to our knowledge, the presence of a SOX2+ (SRY-like homeobox
2) glial progenitor subpopulation, which precedes the expression of
these markers during the differentiation process to glial cells, has
not been reported, although some preliminary studies claim the
possibility of isolating SOX2+ cells from human white matter,
among other brain regions [10]. This transcription factor plays
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critical roles throughout development and is required for the
reprogramming of somatic cells in induced pluripotent cells (iPS)
[11,12]. SOX2 is necessary to maintain pluripotency in embryonic
stem cells regulating key genes such as Oct4 and Nanog, and then
to regulate sequential specification towards the epiblast and the
neuroectoderm [13,14]. Its expression becomes restricted to the
proliferative foetal ventricular zone of the neural tube, and it is
retained in adult neural stem cells [13,15–19]. Similarly, SOX2+
cells have been described as neural stem cells in the human foetal
ventricular zone [20], the adult human subventricular zone (SVZ)
[21], and the subgranular layer (SGL) of the hippocampus [22].
Moreover, SOX2+ cells have been identified as Bergmann glia in
the adult human cerebellum [23].
The aim of this study was to identify new subpopulations of cells
within the OPC pool in the white matter of the adult human brain
that had the potential to generate mature oligodendrocytes, either
in vitro or in vivo. For the first time, we were able to isolate a cell
subpopulation enriched in SOX2+ cells from adult human white
matter, which expanded as floating sphere-like colonies. These
cells acted as glial progenitors in vitro, generating immature (O4+)
and mature (MBP+) oligodendrocytes and, to a lesser extent,
GFAP+ astrocytes. Lastly, we found SOX2+ cells in the original
tissue, most of them co-localised with OLIG2, but not with the
primary microglial, neuronal, or oligodendroglial markers, and
only a small fraction of the cells were GFAP+.
Materials and Methods
DTI and Ki67 Immunohistological Screening of Human
Tissue
Twenty-four samples of adult human brain white matter of
normal appearance were obtained from planned resections during
anterior temporal lobectomy for the treatment of intractable
epilepsy. The procedures were conducted at Hospital La Fe
(Valencia, Spain) and were performed with informed patient
consent that provided their written consent to participate and in
accordance with the medical and science ethics board (Comite´
E´tico de Investigaco´n Biome´dica del hospital Universitario La FE
(CEIB)) that specifically approved the present study.
In order to ensure the absence of abnormalities in the tissue
samples used in the present study, we first analysed the samples
with two different techniques: pre-surgical diffusion tensor imaging
(DTI) and automatised Ki67 immunostaining.
Method of DTI analysis. DTI was used to infer ultrastruc-
tural changes in brain white matter tissue according to the
diffusion of water molecules. The diffusion-weighted images from
all the patients included in this study were acquired using a single-
shot echo-planar imaging pulse sequence with the following
parameters: TR/TE of 10.100/102, acquisition matrix of
1286128, FOV of 250 mm, in-plane resolution of 262 mm and
contiguous 2-mm slice thickness, 70 contiguous axial slices, and a
voxel volume of 1.9561.9562 mm. The images were acquired
with diffusion weighting in 30 non-collinear directions, all with a b
value (diffusion weighting factor) of 1000 s/mm2. In addition, an
image with no diffusion weighting (b value of 0 s/mm2) was
acquired as a reference.
The DTI images were analysed using DTV.II SR toolbox
software (Image Computing and Analysis Laboratory [UTRAD/
ICAL] Department of Radiology, The University of Tokyo
Hospital, extension of Volume 1, package [http://www.volume-
one.org/]) with the following parameters to determine the degree
of sensitivity for generating DTI tracts: Fractional Anisotropy (FA)
= 0.05, steps = 160; Apparent Diffusion Coefficient (ADC) (x1K):
any; So ,80; Angle: any.
Histopathological study. The Ki67 immunohistochemistry
was performed on a benchmark ULTRA using clone 30-9
(Ventana Medical Systems, Tucson, AZ), and interpreted with
an iScan Coreo and Virtuoso algorithm (Ventana Medical
Systems). A histopathological analysis of the tissue samples was
performed to validate their use in the rest of the study. The
architectural disorganisation of the cortex and neuronal hetero-
topia were studied using NeuN immunostaining. Microglia
activation was examined by Iba-1 marking. The experiments
were performed using the protocols described later.
Cell Isolation Protocol and Culture
All samples were processed within 12 hours of extraction
following a previously described protocol [24]. Briefly, brain white
matter was macroscopically separated from temporal grey matter
(Figure S1), minced, and washed in HBSS (Hanks balanced salt
solution) w/o Ca2+/Mg2+. Enzymatic digestion was sequentially
performed with Solution I (Papain [14 U/mL, Sigma] and DNase
I [10 U/mL, Sigma] in PIPES solution) for 90 minutes at 37uC
and Solution II (Papain [7 U/mL] and DNase I [15 U/mL] in
PIPES: proliferative media [1:1]) for 30 minutes at 37uC. The cells
were then dissociated using diameter-decreasing polished Pasteur
pipettes and filtered through a 70-mm mesh. Foetal bovine serum
(10%, Invitrogen) was added to stop enzymatic digestion.
In 10 of the processed samples, the tissue disaggregates were
resuspended in 0.9 M sucrose in 0.5x HBSS w/o Ca2+/Mg2+ and
centrifuged at 750 g for 10 minutes [25]. The dissociated cells
were resuspended in defined proliferative media and were
maintained using standard procedures. Four viable cell cultures
were obtained without sucrose gradient separation and 10 cell
lines from the procedure with sucrose gradient.
The dissociated cells were resuspended in defined proliferative
media composed of DMEM-F12, non-essential amino acids
(100 mm), HEPES (2 mM), D-glucose (30 mM), bovine serum
albumin (0.001%), sodium pyruvate (1 mM), L-glutamine (2 mM),
N2 supplement (1X), penicillin-streptomycin-fungizone (1X) (all
from Gibco-Invitrogen); and hydrocortisone (300 ng/mL) and
triiodothyronine (30 ng/mL) from Sigma. The medium was
supplemented with basic fibroblast growth factor (bFGF) (10 ng/
mL, Sigma) and epidermal growth factor (EGF) (10 ng/mL,
Sigma), and was replaced every two days.
When the cells growing in the monolayer adherent culture
reached a confluence near 90%, a subculture was performed using
Triple Express (Invitrogen) for 5 minutes at 37uC. The cells were
reseeded at a density of 2000 cells/cm2 in 25 cm2 culture flasks.
Using this procedure, all the cell lines could be expanded for at
least seven passages.
The sphere-like clusters obtained using the protocol with the
sucrose centrifugation were passaged before becoming necrotic by
mechanical disaggregation with polished Pasteur pipettes, and
planted at 3000 cells/cm2 on 24-well plates. All the cell lines could
give rise to tertiary neurospheres. Additionally, adherent culture
colonies derived from neurosphere cultures were subcultured
separately according to monolayer culture protocol, and were able
to reach a minimum of five passages.
Three adherent culture cell lines produced by the spheres were
seeded on ultra-low attachment at a density of 3000 cells/cm2,
with or without 100-mM b-mercaptoethanol (Sigma) to test if they
were able to regenerate floating cultures [26]. Viability was studied
using Calcein/I Propidium iodide. After two weeks, the cells were
seeded on Matrigel-coated coverslips, cultured for 24 hours, and
fixed for SOX2 immunostaining (Figure 1A displays a schematic
representation of the different cell cultures).
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Cell Differentiation
Spontaneous differentiation was assayed on small spheres
formed two days after disaggregation, corresponding to four
samples in triplicate. The spheres were seeded on matrigel-coated
coverslips and maintained in growth media for 14 days prior to
fixation.
A protocol directed to induce final oligodendroglial differenti-
ation was tested in four samples in triplicate as previously
described. The spheres were disaggregated into a single-cell
suspension and seeded on a Matrigel-coated coverslip. The cells
were maintained in an oligodendrocyte proliferative medium until
confluence, composed of DMEM-F12, non-essential amino acids
(100 mm), HEPES (2 mM), D-glucose (30 mM), bovine serum
albumin (0.001%), sodium pyruvate (1 mM), L-glutamine (2 mM),
N2 supplement (1X), and penicillin-streptomycin-fungizone (1X),
all of which were acquired from Gibco-Invitrogen. The medium
also included progesterone (300 ng/mL) and sodium selenite
(30 ng/mL), which were acquired from Sigma. The medium was
supplemented with bFGF (20 ng/mL, Sigma), platelet-derived
growth factor alpha (PDGFa, 20 ng/mL, Sigma), and Neurotro-
phin-3 (2 ng/mL, Sigma). The medium was replaced every two
days. When the cells reached confluence, the medium was
supplemented with foetal bovine serum (2%, Gibco) and
triiodothyronine (30 ng/mL, Sigma), and the cells were main-
tained one more week prior to fixation.
Flow Cytometry
Twenty-four hours after cell isolation with the protocol,
including the centrifugation in the sucrose solution, three cell
samples were lightly disaggregated with polished Pasteur pipettes
and washed once with 0.1 M PBS. The cell suspension was then
incubated in A2B5 hybridoma supernatant (ATCC) for 30
minutes at 4uC, washed with 0.1 M PBS, 0.5% bovine serum
albumin three times, and finally incubated in a secondary antibody
(Alexa Fluor 488 goat anti-mouse, 1:500 in 0.1 M PBS [Invitro-
gen]) and propidium iodide. After a final wash, the samples were
analysed using a Cytomics FC 500 (Beckman Coulter) flow
cytometer.
RT-PCR and QRT-PCR
The total RNA was extracted from three cell lines of each
culture type in passage 2 (spheres) or passage 3 (adherent cultures)
using RNeasy, followed by DNase I treatment, both according to
the manufacturer’s specifications (Qiagen). The cDNA was
synthesised using a High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems). The molecular analyses were performed
by PCR amplification, using primers designed with Primer 3
software (Table S1), followed by electrophoresis in 1.8% agarose
gel. SYBR Green-based QRT-PCR (Applied Biosystems) was run
in a LightCycler 480 Instrument (Roche). The amount of SOX2
cDNA was normalised to the quantity of three housekeeping gene
(b-actin, b-2-microglobulin, and GAPDH) transcripts.
Immunocytochemistry
The cells were plated for 24 hours on Matrigel-treated
coverslips, fixed with 4% paraformaldehyde in 0.1 M PB (Panreac)
for 20 minutes, and washed with Dulbecco’s phosphate-buffered
saline (DPBS, Invitrogen) w/o Ca2+/Mg2+.
The cells were blocked with 10% donkey serum (Jackson
ImmunoResearch) and 0.1% Triton X-100 (Sigma) in 0.1 M
DPBS for 45 minutes. Goat anti-human SOX2 antibody (1:50,
Chemicon), mouse anti-GFAP (1:500, Dako), mouse anti-MAP2
(1:200, Sigma), rat anti-MBP (1:200, Sigma), and/or mouse anti-
human Ki67 antibodies (Dako, 1:250) were applied for 1 hour at
25uC in a blocking solution. For Ki67 immunostaining (rabbit
anti-human Ki67, 1:250, Dako), antigen retrieval was previously
Figure 1. Proliferative cells can be isolated from adult human white matter. A. Diagram depicting the different procedures followed in the
present work for the isolation of proliferative cells from human white matter. B. The cell isolation protocol without (w/o) the sucrose centrifugation
step gives rise to a monolayer culture, which could be expanded more than seven passages. However, only 28.57% of samples generated viable
cultures with this procedure (B). Therefore, we added a final sucrose centrifugation, which allowed the obtaining of sphere-like colonies lightly
adhered to the culture plate from all samples processed (D). These cells generated an adherent culture that could be expanded independently for
more than five passages (E). When the initial spheres were passaged and reseeded at a cell density of 3000 cells/cm2 or higher, new spheres were
obtained (C), which, in turn, generated a new monolayer culture. These spheres could be passaged up to tertiary spheres, similarly to other
proliferative cells isolated from adult human white matter. The scale bars represent 50 mm.
doi:10.1371/journal.pone.0099253.g001
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performed by exposing coverslips to boiling 10 mM sodium
citrate, 0.05% Tween 20, pH 6.0 for 15 minutes.
A2B5 and O4 immunostaining was performed using live cells.
The cells were washed, blocked with 5% goat serum in 0.1 M
DPBS for 30 minutes at 4uC and incubated in primary antibody
(A2B5 clone 105 hybridoma supernatant [ATCC, 1:1]; anti O4
[Millipore, 1:50]) for 45 minutes at 4uC. After washing, the cells
were fixed with 4% PFA for 10 minutes and washed with 0.1 M
DPBS.
Finally, for all cases, after washing, secondary antibodies were
applied for 1 hour in DPBS (Texas Red donkey anti-goat
antibody, 1:150; DyLight 488 Donkey anti-mouse, 1:400 [both
from Jackson InmunoResearch]; Alexa Fluor 488 goat anti-mouse
IgM, 1:500; Alexa Fluor 555 donkey anti-goat, 1:500; Alexa Fluor
488 goat anti-rat, 1:500; Alexa Fluor 488 donkey anti-rabbit,
1:500; Alexa Fluor 647 donkey anti-mouse, 1:500 [all purchased
from Invitrogen]). The cells were washed, counterstained with
DAPI, and mounted with FluorSave (Molecular Probes, Invitro-
gen). The same procedure was performed for U373 cells and/or
glioblastoma multiforme cells as a positive control.
The images were collected with a Leica TCS SP2 AOBS (Leica
Microsystems) inverted laser scanning confocal microscope. All the
confocal images were obtained under identical scan settings. Eight-
bit, 102461024-pixel images were collected for each preparation.
The best focus was based on the highest pixel intensity. Imaging
conditions were identical for all the images. The images were
identically processed using MetaMorph Software (Molecular
Devices).
For the cell recount, at least 10 different images (including at
least five spheres, depending on their size) from three separate
experiments were counted.
Immunohistochemistry for SOX2+ Cells
Sections from four temporal lobe samples were fixed with 4%
PFA for 36 hours. After washing, the sections were cryoprotected
in a 30% sucrose solution overnight and cryosectioned at 14 mm.
The sections were washed with 0.1 M PBS, and antigen retrieval
was performed by immersing the sample in 10 mM sodium citrate,
0.05% Tween 20, pH 6.0 at 95uC–100uC for 1 hour. After
permeabilisation treatment with 0.2% Triton X-100 in PBS for 45
minutes, autofluorescence was partially blocked using Sudan black
staining. The sections were incubated overnight at 4uC with goat
anti-human SOX2 (1:25 in PBS; Chemicon), alone or in
combination with mouse anti-Ki67 (1:250, Dako), mouse anti-
GFAP (1:200, Abcam), mouse anti-NeuN (1:800), rabbit anti-Iba-1
(1:200, Wako), or mouse anti-CNPase (1:200, Sigma). The samples
were then washed and labelled with appropriate secondary
antibodies (Texas Red-conjugated donkey anti-goat antibody
(1:150) and DyLight-conjugated Donkey anti-mouse antibody
(1:400) [both from Jackson ImmunoResearch]; Alexa Fluor 488-
conjugated donkey anti-rabbit antibody [1:500, Molecular
Probes]) for 1 hour at room temperature. After washing, the
nuclei were counterstained with DAPI and sections were mounted
with FluorSave (Molecular Probes, Invitrogen). Surgical samples
from human glioblastomas, which express high levels of SOX2,
were used as a positive control (Figure S6).
The images were collected with an Olympus FW-100 inverted
laser scanning confocal microscope. All the confocal images were
obtained under identical scan settings. Eight-bit, 1024 6 1024-
pixel images were collected for each preparation. The best focus
was based on the highest pixel intensity. Imaging conditions were
identical for all the images. The images were equally processed
using FluorView FV1000 (Olympus).
Statistical Analysis
The data presented in this article represent mean 6 standard
deviation and were calculated using Statistical Package for the
Social Sciences (SPSS, IBM). The FA and ADC means from the
epileptic and contralateral side were compared using Student’s t-
test for paired samples (a =0.01).
Results
Surgical Samples of Brain White Matter from the Anterior
Temporal Lobe of Epileptic Patients do not Display DTI or
Histopathological Abnormalities
The human temporal lobe samples were obtained from patients
with mesial temporal sclerosis (age 17–55 [mean value:
38.53610.98] years, 11 males and 13 females) undergoing surgical
resection (Figure S1). Anterior regions of the temporal lobe were
chosen according to their remoteness to the epileptic focus, the
hippocampus.
As a first approach, and to determine the presence or absence of
abnormalities in the surgical brain tissue used for our study, the
region of white matter from the anterior temporal lobe used in this
study was compared with contralateral areas from the same
patient using diffusion tensor images from the pre-surgical study.
This process determined the integrity of the white matter
architecture and connectivity according to the diffusivity of water
molecules. The diffusion tensor matrix is visualised as an ellipsoid
whose diameter in any direction estimates the diffusivity in that
direction. As seen in the examples (Figure 2A), the prolate
ellipsoids indicate that water diffusion is highly restricted towards
their major principal axis, and, therefore, conserved white matter
fibre tracts [27]. The preservation of axon organisation into tracts
is indicated by the colour code, which represents the orientation of
this primary axis.
Fractional anisotropy (FA) mean, a scalar value between 0 and 1
that measures the directionality of water molecule diffusion,
showed similar values between the affected and the contralateral
white matter (Figure 2B). Analogous results were obtained with
the mean apparent diffusion coefficient (ADC), which takes into
account that the diffusion process is not free in tissues (Figure 2C).
All the tissue samples displayed normal cytoarchitecture or mild
gliosis and showed no evidence of the alterations that had been
described in mesial sclerosis, including diffuse cortical architectural
disorganisation (Figure 2F) of the cortex or neuronal heterotopia
within the white matter (tested with the neuronal nuclei marker
NeuN) (Figure 2D). No microglia activation was detected, as the
cells displayed a resting morphology in the Iba-1 immunostaining
(Figure 2E). Additionally, cell density showed normal values
(Figures 2G and 2I), and Ki67 recounts revealed a number of
cells in the active cycle considered normal, thereby ruling out the
presence of neoplastic proliferation (Figures 2H and 2J).
Isolation of Sphere-like Colonies versus Monolayer Cells
The experiments were initially performed according to the
stem/progenitor cell purification protocol used extensively for
both adult human brain white matter and adult human
neurogenic niches within the SVZ and SGL [9,24,28].
Using this procedure, only four of the 14 samples resulted in
viable cultures (a 28.57% success rate). The dissociated cells
generated adherent colonies that could be expanded as a
monolayer, for a minimum of seven passages (Figure 1B). These
cells suffered a decreasing proliferation rate through subsequent
passages until they became quiescent.
To improve the efficiency of the isolation procedure, we
introduced a final step, consisting of a sucrose gradient that helped
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to remove myelin and cell debris generated during mechanical
disaggregation [25]. As a result, viable cultures were obtained from
all samples processed (10 out of 10). Nevertheless, this modification
led to the purification of a different cell type with a smaller size,
which expanded, forming sphere-like colonies (Figure 1D).
Consistent with previous reports claiming limited self-renewal of
adult glial progenitor cells [5,9], the spheres could be passaged
using mechanical disaggregation for at least two subcultures
(tertiary spheres, but both their number and size decreased
through successive passages) (Figure 1C). Moreover, a seeding
concentration of at least 3000 cells/cm2 was necessary to obtain
viable cultures.
Figure 2. Brain white matter tissue obtained from epileptic patients does not show histopathological abnormalities. A. The DTI
imaging analysis of the temporal areas used in our experiments showed diffusion tensors with elongated ellipsoidal form and grouped colouring,
indicating a conserved white matter ultrastructure similar to the contralateral areas. B–C. The anisotropy of water molecules, quantified by the
fractional anisotropy mean (FA) and the apparent diffusion coefficient mean (ADC), showed no significant differences between both epileptic (black)
and contralateral (grey) white matter zones (p-value: 0.155 and 0.439, respectively) D. No neuronal heterotopia was observed within the white
matter, with only a few neurons NeuN+ rarely spread throughout white matter parenchyma (white arrow). The scale bar represents 20 mm. E.
Microglial Iba-1+ cells showed mainly quiescent morphology, with long branching processes and small cellular bodies. The scale bar represents
100 mm. F. Cortical disorganisation was also discarded by NeuN immunohistochemistry, as the neuronal layer could be perfectly differentiated
(indicated by the roman numerals). The scale bar represents 20 mm. G–J. Haematoxylin-eosin staining revealed a normal cellularity (G) and the Ki67
recounts showed a normal number of cells in active phases of the cell cycle in all samples (H). Glioma tissue was used as positive control (I–J). The
scale bars represent 50 mm.
doi:10.1371/journal.pone.0099253.g002
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These neurosphere-like clusters were also able to generate a
monolayer culture in each passage that could be propagated
separately for at least five passages (Figure 1E).
SOX2 Expression is Restricted to Sphere-forming Cells
To determine the phenotype of the isolated cells and the impact
of the sucrose gradient in the cell type obtained, three cell lines
from each type of culture were used to perform a molecular
characterisation by PCR, using a set of primers designed to detect
molecular markers that have been related to the neural stem cell
phenotype in the bibliography (Table S1).
The analysis revealed that all cell types express NSC cell
markers (Figure 3A). In general, the three cell types coincide in
the expression of the cytoskeleton markers vimentin (VIM) [29]
and nestin (NES) [30], the transcription factor polycomb ring
finger oncogene (BMI-1) [31], and NOTCH1 [32], the transmem-
brane protein that can also act as nuclear factor. The isoform delta
of glial fibrillar acid protein (GFAPd) [33] could be detected in
three samples, although it was more evident in the sphere lines.
Nevertheless, different expression patterns for stem cell genes were
confirmed among the three cell types. While both adherent
cultures showed a very similar profile, the sphere-forming cells
differed in the absence of ATP-binding cassette sub-family G
member 2 (ABCG2) [34], musashi homolog 1 (MSI1) [35,36], and
paired box 6 (PAX6) [37]; the presence of CD133/prominin-1
(PROM1) [38]; and, above all, the more significant expression of
SOX2. This enrichment in SOX2 expression was also detected by
QRT-PCR (Figure 3B). Moreover, immunocytochemistry per-
formed in all samples revealed that the SOX2 protein could be
detected exclusively in spheres cultures, and not in the rest of the
adherent cells (Figure S2). Seven days after isolation, 43.69%
68.92% of the cells were SOX2+. After sphere passage by
mechanical disaggregation, small spheres start to arise, all
containing almost exclusively SOX2+ cells (Figure 3C and
Figure S3). This number is reduced to 80.57%617.20% SOX2+
when the sphere size increases, although all Ki67+ proliferative
cells were SOX2+ (17.45% 65.80%) (Figure 3D).
To determine whether the adherent cells that originated from
spheres were able to recover the sphere phenotype, the cells were
seeded in low adherence conditions [26]. Although a number of
the cells survived and formed small cell aggregates under both
conditions, SOX2 expression was not recovered, and the cells
degenerated and died after two weeks (Figure S4).
The Population Containing SOX2+ Cells Shows Glial
Progenitor Cell Features
The molecular analysis demonstrated that SOX2 enrichment
coincided with changes in the expression of glial genes
(Figure 4A). In addition to the expression of early oligodendro-
cyte commitment markers, such as the alpha subunit of platelet
derived growth factor receptor (PDGFRa), the proteoglycan NG2,
and the enzyme 29, 39-cyclic nucleotide 39-phosphodiesterase
(CNP), the spheres expressed a higher number of oligodendrocyte
progenitor markers, including the transcription factors OLIG1 and
OLIG2, which are necessary for oligodendrocyte differentiation,
and the isoform DM20 of the gene proteolipid protein (PLP) [39].
Moreover, the expression of the myelin-specific genes myelin acid
glycoprotein (MAG), PLP, and myelin basic protein (MBP) was also
detected, although not the gene myelin oligodendrocyte glycopro-
tein (MOG).
All the sphere samples expressed the three astroglial markers
studied: the astrocyte precursor marker CD44 [40], the calcium
binding protein S100B, and the isoform alpha of the GFAP gene.
Regarding the expression of neuronal precursor markers, micro-
tubule associated protein 2 (MAP2) and b-3-tubulin (TUBB3) were
detected in the three cell types, but not doublecortin (DCX).
The presence of A2B5 [41], the conventional marker to detect
oligodendrocyte progenitor cells, and the pre-oligodendrocyte
marker O4, was also confirmed by immunocytochemistry in initial
sphere cultures, but it was undetectable in the other cell types
(Figure 4C and Figure S5B). Nevertheless, the FACS analysis
indicated that the vast majority of sphere cells isolated in the
protocol with sucrose gradient were A2B52 (Figure 4B and
Figure S5A). Thus, the cell population, which contained SOX2+
cells, seemed different from the A2B5+ population previously
described, with about 100-fold fewer A2B5+ cells [9].
SOX2+ Cells Generate Immature O4+ and Mature MBP+
Oligodendrocytes
To examine their spontaneous differentiation in media
containing growth factors, small spheres were seeded onto
Matrigel-coated coverslips and left to grow undisturbed for 14
days. During this time, cell extensions started to arise from the
sphere, which slowed their growth, suggesting that the attachment
was limiting cell proliferation. When immunostaining was
performed, a decrease in the SOX2+ cell number was observed
(45.38% 620%). All the spheres were positive for the surface
marker O4, one of the earliest antigens expressed in cells
committed to the oligodendroglial lineage. Therefore, cell
extensions corresponded to these small O4+ cells (58.35%
621.11%), with 46.92% 624.73% of them SOX2+/O4+
(26.72% 614.25% of the total number of cells). We also found
GFAP+ astrocytic cells (10.01% 63.06%), all of which showed
higher SOX2+ immunoreactivity (Figures 5A–5B). Note that, as
shown in the image, the astrocytes were large, flattened, and
expanded cells, with a larger nucleus, and tended to exit from the
sphere core. Nonetheless, no MAP2+ neuronal/neuroblast cells
were observed (Figure 5D). Finally, a directed differentiation
procedure was performed, seeding single cells in oligodendrocyte
proliferative medium until a high density was reached (which has
been described as useful in achieving oligodendrocyte differenti-
ation [9]), and the medium was then supplemented with foetal
serum. All the surviving cells displayed an oligodendrocyte-like
shape and positive immunoreaction directed against the myelin
protein MBP, which could not be detected prior to the
differentiation protocol (Figure 5C). Therefore, SOX2+ cells
from adult white matter can be considered glial progenitor cells
and are able to generate O4+ immature and MBP+ mature
oligodendrocytes and, to a lesser extent, GFAP+ astrocytes.
SOX2+ Cells are Present in Adult Human Brain White
Matter
After the discovery of this SOX2+ cell subpopulation in vitro, we
analysed four tissue samples of adult human white matter from the
temporal lobe to determine whether these cells could be found
in vivo. We detected the presence of SOX2+ cells in all the samples
analysed. The cells rarely appeared, and were scattered through-
out the white matter, although at times, the cells were
concentrated in small areas. Their number was similar among
the samples, representing approximately 2.01% 60.73% of the
total number of cells.
Co-immunostaining with specific markers for the different cell
lineages present in the brain was performed to determine the
SOX2+ cell phenotype. No co-staining with Iba-1 was found,
discarding the microglial identity of SOX2+ cells (Figure 6A).
Similarly, no co-localisation with CNPase or NeuN (Figures 6B–
6C) was detected, which supports the idea that the SOX2+ cell
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subpopulation does not correspond to a differentiated oligoden-
droglial or neuronal population, respectively. On the other hand,
the GFAP immunohistochemistry revealed a low proportion of co-
immunolocalisation with SOX2+ cells in all the samples studied,
always lower than the number of GFAP2 SOX2+ cells
(Figure 6D). These GFAP+ SOX2+ (Figure 6E) astrocytes have
many branching processes extended radially from the perinucleus,
in contrast to the normal fibrous astrocytes present in white matter
parenchyma.
Finally, as previously reported [42,43], OLIG2 immunostaining
distinguished two OLIG2+ cell populations (Figure 6F): the first,
tenuously stained, corresponding to mature oligodendrocytes
(OLIG2low); and the second, less abundant but expressing a
higher level of OLIG2 (OLIG2high), identified as glial progenitors
in adult human white matter. Interestingly, although we observed
SOX2+ OLIG2low and SOX2+ OLIG22 cells, the confocal study
revealed that most SOX2+ cells correspond to OLIG2high cells.
Therefore, SOX2+ cells present in adult human brain white
matter show features of glial progenitor cells that can be correlated
with the SOX2+ enriched cell population isolated in vitro, which is
able to generate O4+ immature and MBP+ mature oligodendro-
cytes and, to a lesser extent, GFAP+ astrocytes.
Figure 3. Cells isolated from adult human white matter differentially express neural stem cell related markers. A. The molecular
characterisation by PCR of stem cell markers revealed a different pattern of gene expression among the three types of cell lines. Both adherent
cultures types showed a very similar profile, and the sphere-forming cells differed in the absence of ABCG2, MSI1, and PAX6; the presence of PROM1 in
all samples; and, above all, a higher expression of SOX2. Primers, band size, and positive controls can be consulted in Table S1. B. QRT-PCR
confirmed that spheres (SPH) express more SOX2 mRNA than both adherent culture types. Bars represent mean 6 standard deviation. C. After
mechanical disaggregation to single cell suspension of primary spheres, small spheres started to grow, almost all the cells of which were SOX2+. The
small white arrows indicate SOX2+ spheres, whereas the asterisk is marking a SOX22 cell, which does not generate spheres. D. When these spheres
became larger, the number of SOX2+ cells was reduced to 80.57% 617.20%. All Ki67+ cells were SOX2+ (large white arrows). The scale bar represents
100 mm. The SOX2 protein could only be detected in the spheres (see Figure S2).
doi:10.1371/journal.pone.0099253.g003
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Discussion
In this report, we describe for the first time the isolation of a
SOX2+ glial progenitor cell subpopulation from adult human
white matter. This small population of SOX2+ cells was also
detected in situ and, in general, did not co-stain with any
differentiated markers of the three main neuronal lineages or
microglia.
SOX2 protein is involved in adult neural stem cell phenotype
maintenance, proliferation, and subsequent differentiation [44]. In
our in vitro studies, only the neurosphere-like clusters contained
SOX2+ cells, a culture system commonly associated with neural
Figure 4. SOX2+-enriched cell population expresses glial progenitor signatures. A. The molecular characterisation by PCR showed that
sphere-forming cells express a higher number of oligodendrocyte markers than either adherent culture (the cell monolayers obtained without the
sucrose centrifugation step and those derived from spheres). In addition to the initial oligodendrocyte markers PDGFRA, NG2, and CNP, they express
oligodendrocyte progenitor markers OLIG1 and OLIG2, or the isoform DM20 of PLP, and mature myelin proteins such as PLP, MAG, and MBP. Moreover,
the three astrocytic markers (CD44, GFAP, and S100B) tested were also detected in the sphere culture. No difference in the neuronal markers was
observed among the three culture types. B. FACS showed that only 0.04% of the isolated cells correspond to A2B5+/PI+ (region R4). C. Similarly, only
a few A2B5+ cells were detected in primary spheres (the A2B5+ cell perinucleus in the image is indicated by the arrow), whereas more O4+ pre-
oligodendrocytic cells were found. The scale bars represent 20 mm and 50 mm, respectively. Negative controls for FACS and immunocytochemistry
can be found in Figure S5.
doi:10.1371/journal.pone.0099253.g004
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Figure 5. SOX2+ cells act as a glial progenitor in vivo. A–B. After the spontaneous differentiation protocol of small spheres, the number of
SOX2+ cells decreased, accompanied by the emergence of O4+ cell processes, which correspond to 58.35% 621.11% of total cells. A small number of
GFAP+ cells could be also detected (10.01% 63.06%), all of them SOX2+. The scale bar represents 25 mm. C. SOX2+ population exhibits morphology
compatible with oligodendroglial differentiation after the directed differentiation protocol, which was confirmed by the detection of myelin protein
MBP. The scale bars represent 50 mm. D. No neuronal MAP2+ cells were observed in the spheres after the spontaneous differentiation of sphere-
forming cells. Primary cell cultures derived from glioblastoma were used as a positive control. The scale bars represent 20 mm.
doi:10.1371/journal.pone.0099253.g005
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Figure 6. SOX2+ cells are present in adult temporal lobe white matter. SOX2+ cells can be found scattered within white matter. We do not
detect NeuN+/SOX2+ neuronal cells (A), Iba-1+/SOX2+ microglial cells (B), or CNPase+/SOX2+ differentiated oligodendrocytes (C). Although the vast
majority of SOX2+ cells were GFAP2 (D), some of them were GFAP+ astrocytes with more activated morphology (E). F. Finally, most of the SOX2+ cells
corresponded to OLIG2high, which are thought to be oligodendrocyte progenitor cells in adult brain white matter. SOX2+/OLIG2low and SOX2+/
OLIG22 could be also found in all samples. The scale bars represent 20 mm. Glioblastoma sections used as positive controls are collected in Figure
S6.
doi:10.1371/journal.pone.0099253.g006
New Glial Progenitor Cell Population in the Adult Human Brain
PLOS ONE | www.plosone.org 10 June 2014 | Volume 9 | Issue 6 | e99253
stemness. These results agree with previous reports, in which
SOX2 expression was shown necessary for the formation of
spheres from adult human spinal cord tissue [45], human foetal
VZ tissue [20], and rodent tissue [13,16]. Furthermore, SOX2
induction is sufficient to transform human astrocytes into NSC-
forming sphere-like colonies [46].
Nevertheless, sphere cultures are not exclusive to the neural
stem cell phenotype, given that oligodendrocyte progenitors can
also generate floating cell aggregates, known as oligospheres
[47,48]. Immunostaining revealed the presence of both glial
populations, oligodendroglial and astroglial cells in the same
sphere, but an absence of MAP2+ cells, indicating a bi-lineage
competence, which is similar to that repeatedly established for
previously described glial progenitors. This enrichment of glial
gene expression in SOX2+ cells has also been found in foetal tissue
[20] and adult SVZ tissue [21], where SOX2 expression has been
associated with glial fate. It is known that SOX2 acts as a SOX11
activator, a transcription factor expressed in earlier oligodendro-
cyte progenitor commitment, and is lost after full differentiation.
Other genes related to oligodendrocyte differentiation, such as
PDGFRa, OLIG2, and NG2, have been found to respond directly
to SOX2 variations [20]. According to our data, we hypothesise
that SOX2+ cells correspond to the population of glial restricted
progenitors which, in normal culture conditions, give rise to
immature O4+ oligodendrocyte cells (that finally lose SOX2
expression), and a small percentage of astrocytic GFAP+ cells.
Moreover, it is possible to induce their differentiation towards
myelinating MBP+ oligodendrocytes with PDFGF/FGF/NT3
treatment followed by FBS exposure (Figure 7). However, we
found an almost total absence of A2B5+ cells, whereas the glial
progenitor populations already described were mostly overlapping
and contained a big amount of A2B5+ cells [3–5].
This finding, together with the survival and proliferation of the
isolated cell population in FGFb- but not PDGFa-supplemented
medium, suggest that the SOX2+ population could correspond to
a state prior to their commitment towards an oligodendrocyte
progenitor cell (A2B5+/SOX22) or even glial restricted progenitor
cells (A2B5+/SOX2+) [49,50]. Therefore, as SOX2+ cells have
also been found to generate neurons under the appropriate
conditions [10,13,20], we cannot reject the possibility that under
specific culture conditions, our cells might behave as true neural
stem cells in vitro and not just as glial progenitors. This same
situation has been described for the A2B5+ OPC population [3–5].
SOX2 expression has also been related to a lower self-renewal
in vitro in adult cells, a characteristic of progenitor cells. We were
unable to expand SOX2+ cells for more than three passages,
which, at first glance, might limit their use in cell replacement
therapies. However, the presence of SOX2, together with
increasing knowledge regarding the production of iPS cells using
penetrating peptides (CPPs) [51], and the factors recently reported
as modulating the biology of these SOX2+ cells [52–54], might
help in the future to either modulate their behaviour in vivo or
expand the SOX2+ progenitor cells in vitro before transplantation
into chronic sclerotic MS plaques.
Beyond the discovery of these SOX2+ cells in vitro, we have also
been able to identify SOX2+ cells in adult human normal-
appearing brain white matter. Previous studies focusing on
neoplastic or epileptic pathologies [55,56] have shown that
SOX2+ cells were present in the temporal cortex obtained from
normal post-mortem tissue, but in what they considered to be
negligible amounts. One of these analyses found a slight increase
in SOX2+ cells in temporal mesial sclerosis, although it was not
statistically significant in contrast to recounts performed in other
epileptic pathologies.
During the characterisation of the SOX2+ cells, no co-
immunolocalisation with neuronal or mature oligodendroglial
markers was found, and only a small fraction of GFAP+ cells were
discovered. This finding contrasts with the distribution reported in
mice and rats [16,17], in which virtually all SOX2+ cells scattered
across the cortex corresponded to GFAP+ astrocytes. In our study
tissue, SOX2+/GFAP+ might represent a reactive glial population
due to epileptic injury, a factor that has been shown to be sufficient
to reactivate SOX2 expression in quiescent astrocytes [57,58].
This phenomenon might explain the slight increase in SOX2+ cells
in mesial sclerosis. Thus, we may have a similar situation to that
observed when oligodendrocyte progenitor cells were first
described in human white matter, in which a small percentage
of these cells were GFAP+ in epileptic samples; however, this
phenotype was absent in normal tissue [3].
Figure 7. Schematic diagram representing our hypothesis about SOX2+ cell evolution in vitro. According to our findings, we hypothesise
that SOX2+ cells correspond to glial restricted progenitors, spontaneously differentiating to O4+ pre-oligodendrocytes that finally lose SOX2
expression. In addition, a small number of GFAP+ astrocytes is generated. Finally, after exposure to the appropriate growth factors, SOX2+ cells are
able to generate oligodendrocytes that express mature myelinating oligodendrocyte proteins such as MBP.
doi:10.1371/journal.pone.0099253.g007
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Nevertheless, the most relevant co-localisation of this study is
the discovery of the OLIG2high/SOX2+ population. It has been
reported that the OLIG2high cell population–which expresses
higher OLIG2 levels than mature oligodendrocytes–corresponds
with practically all the proliferative cells present in adult human
white matter [42,43]. In mice, they generate oligodendrocytes as
part of the normal replacement in the white matter. Furthermore,
OLIG2+ cells are recruited by demyelinated plaques, even
generating mature oligodendrocytes in early lesions [59]. Accord-
ingly, this OLIG2+ SOX2+ cell pool could be responsible for the
spontaneous remyelination observed in some patients [6,60].
Therefore, according to their immunophenotype in the tissue,
the behaviour of their in vitro counterparts, and the previous
progenitor cells found in this tissue, our data suggest that this
SOX2 population may represent a glial progenitor source within
the adult human brain parenchyma. However, the limited
availability of these precious adult human brain samples, both in
size and number, reduces the number of assays and replicates
that can be carried out, and further experiments to demonstrate
the myelination capacity both in vitro and in vivo will be needed.
The discovery of this new type of progenitor cell opens the
possibility of designing cellular therapy strategies directed at
mobilising these cells towards damaged areas to accomplish a
functional cell replacement. Our isolated cells offer an in vitro
model for further characterisation of their proliferative signal
response and differentiation potential in order to modulate their
activity in vivo.
Supporting Information
Figure S1 Sections of adult white matter from the
temporal lobe obtained from patients who underwent
surgical resection. As observed in the examples, brain white
matter can be visually distinguished from the cortical grey matter.
This characteristic allowed not only the macrodissection per-
formed in the cell isolation protocol, but also the identification of
regions of interest in cryosections without the necessity of including
specific markers.
(TIF)
Figure S2 SOX2 is only detectable in sphere cultures.
Immunohistochemistry against SOX2 (red) and Ki67 (green) of
adherent cells from the protocol without the sucrose gradient
centrifugation (ADH, A–B) and adherent cells produced by sphere
cultures (ADH SPH, E–H). No SOX2 was detected in either of the
two samples. U373 cells were used as positive control (Control, I–
L). The scale bar represents 20 mm.
(TIF)
Figure S3 Small secondary spheres derived after me-
chanical disaggregation are mainly SOX2+. The panel
shows SOX2 immunostaining for 10 spheres from three different
samples (1–3 correspond to the first sample, 4–6 to the second
sample, and 7–10 to the third sample). Some cells show a high
expression of SOX2 and others a lower expression. The scale bar
represents 10 mm. The cell recount reveals that 97.14 were
SOX2+ cells.
(TIF)
Figure S4 Adherent cells generated from spheres can-
not produce floating cultures. A. Cells from adherent
cultures were cultured in non-adherent conditions and maintained
in media supplemented with growth factors for 14 days (n = 3).
During this time, some cell aggregates were observed, but they
degenerated at the end of the experiment. Cell survival was
studied using propidium iodide (B) and calcein (C). D. If these cell
clusters were plated again in adherent conditions for 24 hours
before fixation, they generated a monolayer, without the
expression of SOX2 being detected by immunocytochemistry.
The scale bar represents 100 mm (E).
(TIF)
Figure S5 Negative controls for FACS analysis and
A2B5/O4 immunostaining. A. A small fraction of cells
isolated using the protocol with the sucrose centrifugation was
only stained with the secondary antibody, in order to delimitate
the gates corresponding to real A2B5 staining. B. Similarly, when
A2B5/O4 immunostaining was performed, a negative control
without primary antibody was included to detect autofluorescence.
As observed in the example, the primary spheres include an
important quantity of cell debris in which fluorescence can be
detected. The scale bar represents 50 mm.
(TIF)
Figure S6 Glioblastoma multiforme tissue expressing
high levels of SOX2 was used as a positive control. Panel
shows double immunostaining against SOX2 (red) combined with
Iba-1 (A–D), CNPase (E–H), NeuN (I–L), and GFAP (M–P). The
scale bars represent 100 mm (D, H) or 30 mm (L, P).
(TIF)
Table S1 A set of primers for stem cell markers and
markers for each neural lineage were designed using
Primer 3 software. After ensuring their efficiency, molecular
analyses were performed by PCR amplification followed by
electrophoresis in 1.8% agarose gel. Positive and negative controls
were used for each marker according to the literature. *PLP/
DM20 primers [61] generate two bands: one of them correspond-
ing to the mature form PLP (247 pb) and the other to the isoform
DM20, expressed in oligodendrocyte progenitor cells (120 pb).
(TIF)
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